Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natalia Fernandez

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Frontiers in Oncology|May 22, 2024
Outcomes and patterns of use of Radium-223 in metastatic castration-resistant prostate cancerUrbano Anido-Herranz, Ovidio Fernandez-Calvo, Juan Ruiz-Bañobre, et al.
Plos One|August 8, 2012
A phase I double blind, placebo-controlled, randomized study of a multigenic HIV-1 adenovirus subtype 35 vector vaccine in healthy uninfected adultsMichael C Keefer, Jill Gilmour, Peter Hayes, et al.
Journal of Clinical Epidemiology|March 10, 2021
The methodological quality is insufficient in clinical practice guidelines in the context of COVID-19: systematic reviewTanja A Stamm, Margaret R Andrews, Erika Mosor, et al.
AIDS Research and Human Retroviruses|October 29, 2021
HIV Prevention in a Time of COVID-19: A Report from the HIVR4P // Virtual Conference 2021Fatima Laher, Simone I Richardson, Philip Smith, et al.
BMJ (Clinical Research Ed.)|March 3, 2021
SARS-CoV-2 lateral flow assays for possible use in national covid-19 seroprevalence surveys (React 2): diagnostic accuracy studyMaya Moshe, Anna Daunt, Barnaby Flower, et al.
The New England Journal of Medicine|November 5, 2025
Safety and Immunogenicity of an rVSV Lassa Fever Vaccine CandidateElissa Malkin, Marija Zaric, Mark Kieh, et al.
Journal of Virological Methods|January 25, 2022
Detection and quantification of antibody to SARS CoV 2 receptor binding domain provides enhanced sensitivity, specificity and utilityCarolina Rosadas, Maryam Khan, Eleanor Parker, et al.
Thorax|August 16, 2020
Clinical and laboratory evaluation of SARS-CoV-2 lateral flow assays for use in a national COVID-19 seroprevalence surveyBarnaby Flower, Jonathan C Brown, Bryony Simmons, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2024
Biological Sample Collection to Advance Research and Treatment: A Fight Osteosarcoma Through European Research and Euro Ewing Consortium StatementDarrell Green, Roelof van Ewijk, Elisa Tirtei, et al.
The Lancet. Microbe|May 19, 2025
Safety and broad immunogenicity of HIVconsvX conserved mosaic candidate T-cell vaccines vectored by ChAdOx1 and MVA in HIV-CORE 006: a double-blind, randomised, placebo-controlled phase 1 trial in healthy adults living without HIV-1 in eastern and southern AfricaChama Chanda, Freddie Kibengo, Michael Mutua, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Frontiers in Oncology|May 22, 2024
Outcomes and patterns of use of Radium-223 in metastatic castration-resistant prostate cancerUrbano Anido-Herranz, Ovidio Fernandez-Calvo, Juan Ruiz-Bañobre, et al.
Plos One|August 8, 2012
A phase I double blind, placebo-controlled, randomized study of a multigenic HIV-1 adenovirus subtype 35 vector vaccine in healthy uninfected adultsMichael C Keefer, Jill Gilmour, Peter Hayes, et al.
Journal of Clinical Epidemiology|March 10, 2021
The methodological quality is insufficient in clinical practice guidelines in the context of COVID-19: systematic reviewTanja A Stamm, Margaret R Andrews, Erika Mosor, et al.
AIDS Research and Human Retroviruses|October 29, 2021
HIV Prevention in a Time of COVID-19: A Report from the HIVR4P // Virtual Conference 2021Fatima Laher, Simone I Richardson, Philip Smith, et al.
BMJ (Clinical Research Ed.)|March 3, 2021
SARS-CoV-2 lateral flow assays for possible use in national covid-19 seroprevalence surveys (React 2): diagnostic accuracy studyMaya Moshe, Anna Daunt, Barnaby Flower, et al.
The New England Journal of Medicine|November 5, 2025
Safety and Immunogenicity of an rVSV Lassa Fever Vaccine CandidateElissa Malkin, Marija Zaric, Mark Kieh, et al.
Journal of Virological Methods|January 25, 2022
Detection and quantification of antibody to SARS CoV 2 receptor binding domain provides enhanced sensitivity, specificity and utilityCarolina Rosadas, Maryam Khan, Eleanor Parker, et al.
Thorax|August 16, 2020
Clinical and laboratory evaluation of SARS-CoV-2 lateral flow assays for use in a national COVID-19 seroprevalence surveyBarnaby Flower, Jonathan C Brown, Bryony Simmons, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2024
Biological Sample Collection to Advance Research and Treatment: A Fight Osteosarcoma Through European Research and Euro Ewing Consortium StatementDarrell Green, Roelof van Ewijk, Elisa Tirtei, et al.
The Lancet. Microbe|May 19, 2025
Safety and broad immunogenicity of HIVconsvX conserved mosaic candidate T-cell vaccines vectored by ChAdOx1 and MVA in HIV-CORE 006: a double-blind, randomised, placebo-controlled phase 1 trial in healthy adults living without HIV-1 in eastern and southern AfricaChama Chanda, Freddie Kibengo, Michael Mutua, et al.
Pageof 6